ROLE OF ARTIFICIAL SWEETENERS IN DIABETES MANAGEMENT: EFFICACY, SAFETY AND EMERGING EVIDENCE

Diabetes mellitus is a growing metabolic health challenge in which dietary choices play an important role in maintaining glycemic control and reducing long-term complications. Artificial sweeteners, also referred to as non-nutritive sweeteners, have gained considerable attention as alternatives to conventional sugars because they provide intense sweetness with little or no energy and generally cause a minimal immediate rise in blood glucose. This has led to their increasing use in foods and beverages intended for individuals with diabetes and those seeking better weight and calorie control. However, their role in diabetes management is more complex than simply replacing sugar with a low-calorie alternative. This review examines the current evidence regarding the efficacy, safety, and potential metabolic effects of artificial sweeteners, with emphasis on glycemic control, body weight, insulin sensitivity, and overall metabolic health. The review also explores emerging evidence suggesting that certain sweeteners may interact with the gut microbiota and influence glucose metabolism, highlighting the possibility of individual variations in metabolic response. Although controlled studies indicate that replacing added sugars with non-nutritive sweeteners may help reduce energy and carbohydrate intake, evidence regarding their long-term effects on diabetes-related outcomes remains inconsistent. Therefore, artificial sweeteners may have a potential role as an adjunct to dietary management rather than as a stand-alone strategy for diabetes control. A better understanding of dose, duration, individual response, and specific sweetener type is essential for establishing evidence-based recommendations. Future research should focus on long-term clinical studies and personalized nutritional approaches to clarify whether artificial sweeteners are merely sugar substitutes or active modulators of metabolic health.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-01
DOI
https://doi.org/10.5281/zenodo.23801890
Primary Topic
Biochemical Analysis and Sensing Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ROLE OF ARTIFICIAL SWEETENERS IN DIABETES MANAGEMENT: EFFICACY, SAFETY AND EMERGING EVIDENCE

Zehra Husaini*1, Sahil Srivastava2, Mohammad Shawwal3
3 links
Zenodo (CERN European Organization for Nuclear Research)
Biochemical Analysis and Sensing Techniques
article

ROLE OF ARTIFICIAL SWEETENERS IN DIABETES MANAGEMENT: EFFICACY, SAFETY AND EMERGING EVIDENCE

Zehra Husaini*1, Sahil Srivastava2, Mohammad Shawwal3
article en

Abstract

Diabetes mellitus is a growing metabolic health challenge in which dietary choices play an important role in maintaining glycemic control and reducing long-term complications. Artificial sweeteners, also referred to as non-nutritive sweeteners, have gained considerable attention as alternatives to conventional sugars because they provide intense sweetness with little or no energy and generally cause a minimal immediate rise in blood glucose. This has led to their increasing use in foods and beverages intended for individuals with diabetes and those seeking better weight and calorie control. However, their role in diabetes management is more complex than simply replacing sugar with a low-calorie alternative. This review examines the current evidence regarding the efficacy, safety, and potential metabolic effects of artificial sweeteners, with emphasis on glycemic control, body weight, insulin sensitivity, and overall metabolic health. The review also explores emerging evidence suggesting that certain sweeteners may interact with the gut microbiota and influence glucose metabolism, highlighting the possibility of individual variations in metabolic response. Although controlled studies indicate that replacing added sugars with non-nutritive sweeteners may help reduce energy and carbohydrate intake, evidence regarding their long-term effects on diabetes-related outcomes remains inconsistent. Therefore, artificial sweeteners may have a potential role as an adjunct to dietary management rather than as a stand-alone strategy for diabetes control. A better understanding of dose, duration, individual response, and specific sweetener type is essential for establishing evidence-based recommendations. Future research should focus on long-term clinical studies and personalized nutritional approaches to clarify whether artificial sweeteners are merely sugar substitutes or active modulators of metabolic health.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 13%
Biochemical Analysis and Sensing Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon